Hsiang, C.-Y.; Hsu, K.-T.; Lo, H.-Y.; Hou, Y.-J.; Ho, T.-Y.
2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation. Nutrients 2025, 17, 1835.
https://doi.org/10.3390/nu17111835
AMA Style
Hsiang C-Y, Hsu K-T, Lo H-Y, Hou Y-J, Ho T-Y.
2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation. Nutrients. 2025; 17(11):1835.
https://doi.org/10.3390/nu17111835
Chicago/Turabian Style
Hsiang, Chien-Yun, Kuang-Ting Hsu, Hsin-Yi Lo, Yun-Jhu Hou, and Tin-Yun Ho.
2025. "2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation" Nutrients 17, no. 11: 1835.
https://doi.org/10.3390/nu17111835
APA Style
Hsiang, C.-Y., Hsu, K.-T., Lo, H.-Y., Hou, Y.-J., & Ho, T.-Y.
(2025). 2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation. Nutrients, 17(11), 1835.
https://doi.org/10.3390/nu17111835